Healthcare - Medical - Devices - NASDAQ - US
$ 17.25
1.47 %
$ 253 M
Market Cap
-2.6
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
8.88%
EBIT
Estimate
33.93%
Net Income
Estimate
22.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Anika Therapeutics, Inc.
ANIK has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ANIK
EBIT FORECAST
EBIT Forecast Chart ANIK
NET INCOME FORECAST
Net Income Chart ANIK